Literature DB >> 23456986

Cadaveric donor lobar lung transplantation for patients on extracorporeal membrane oxygenation as bridge-to-transplant.

Yoshiya Toyoda1.   

Abstract

The total number of lung transplants reported to the International Society of Heart and Lung Transplantation registry continues to increase steadily. In the US, the lung transplant volume has increased from 1172 in 2004 to 1822 in 2011 since lung allocation score system was implemented in 2005 while the overall 1-year survival after transplantation has not changed significantly. One of the most common reasons why lung offers are declined is size-mismatch. Size-reduced lung transplantation including non-anatomical lung volume reduction and lobar lung transplantation is an advanced surgical technique to alleviate donor organ shortage. Living-related donor lung transplantation almost disappeared in the US, but alternatively, we perform lobar transplantation using cadaveric donor lungs. With recent advances in extracorporeal membrane oxygenation (ECMO) technology and surgical experience, ECMO has been used before, during and after lung transplant surgery successfully.

Entities:  

Mesh:

Year:  2013        PMID: 23456986     DOI: 10.1007/s11748-013-0220-x

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  11 in total

Review 1.  Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era.

Authors:  Graeme MacLaren; Alain Combes; Robert H Bartlett
Journal:  Intensive Care Med       Date:  2011-12-07       Impact factor: 17.440

Review 2.  Update on living-donor lobar lung transplantation.

Authors:  Hiroshi Date
Journal:  Curr Opin Organ Transplant       Date:  2011-10       Impact factor: 2.640

3.  Assessment of lungs rejected for transplantation and implications for donor selection.

Authors:  Lorraine B Ware; Yibing Wang; Xiaohui Fang; Martha Warnock; Tsutomu Sakuma; Timothy S Hall; Michael Matthay
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

4.  Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation.

Authors:  N Mogulkoc; M H Brutsche; P W Bishop; S M Greaves; A W Horrocks; J J Egan
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

5.  Living-donor lobar lung transplantation experience: intermediate results.

Authors:  V A Starnes; M L Barr; R G Cohen; J A Hagen; W J Wells; M V Horn; F A Schenkel
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

6.  Size-reduced lung transplantation: an advanced operative strategy to alleviate donor organ shortage.

Authors:  C Aigner; G Winkler; P Jaksch; J Ankersmit; G Marta; S Taghavi; W Wisser; W Klepetko
Journal:  Transplant Proc       Date:  2004-11       Impact factor: 1.066

7.  Should lung transplantation be performed for patients on mechanical respiratory support? The US experience.

Authors:  David P Mason; Lucy Thuita; Edward R Nowicki; Sudish C Murthy; Gösta B Pettersson; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2010-03       Impact factor: 5.209

8.  Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation.

Authors:  Yoshiya Toyoda; Jay K Bhama; Norihisa Shigemura; Diana Zaldonis; Joseph Pilewski; Maria Crespo; Christian Bermudez
Journal:  J Thorac Cardiovasc Surg       Date:  2013-01-16       Impact factor: 5.209

9.  Matching donor to recipient in lung transplantation: How much does size matter?

Authors:  David P Mason; Lillian H Batizy; Jeffrey Wu; Edward R Nowicki; Sudish C Murthy; Ann M McNeill; Marie M Budev; Atul C Mehta; Gösta B Pettersson; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2009-05       Impact factor: 5.209

10.  A decade of living lobar lung transplantation: recipient outcomes.

Authors:  Vaughn A Starnes; Michael E Bowdish; Marlyn S Woo; Richard G Barbers; Felicia A Schenkel; Monica V Horn; Renzo Pessotto; Eric M Sievers; Craig J Baker; Robbin G Cohen; Ross M Bremner; Winfield J Wells; Mark L Barr
Journal:  J Thorac Cardiovasc Surg       Date:  2004-01       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.